IN8bio (INAB) News Today $0.24 0.00 (-1.34%) Closing price 03/11/2025 04:00 PM EasternExtended Trading$0.24 0.00 (-0.74%) As of 07:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period IN8bio (INAB) to Release Quarterly Earnings on ThursdayMarch 11 at 2:05 AM | americanbankingnews.comIN8bio announces board member resignationMarch 7, 2025 | uk.investing.comIN8bio, Inc: IN8bio Announces Advanced Gamma-Delta T cell Engager (TCE) Platform for Oncology and Autoimmune DiseasesMarch 3, 2025 | finanznachrichten.deIN8bio announces gamma-delta T cell enager platformMarch 3, 2025 | markets.businessinsider.comIN8bio Announces Advanced Gamma-Delta (γδ) T cell Engager (TCE) Platform for Oncology and Autoimmune DiseasesMarch 3, 2025 | globenewswire.comIN8bio to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | globenewswire.comIN8bio to Present at the H.C. Wainwright 3rd Annual Cell Therapy Virtual ConferenceFebruary 24, 2025 | globenewswire.comINAB: Continued Survival in INB-100 TrialFebruary 19, 2025 | finance.yahoo.comIN8bio Inc Ordinary SharesFebruary 14, 2025 | morningstar.comIN8bio reports promising phase 1 results for leukemia therapyFebruary 14, 2025 | msn.comIN8bio presented Phase 1 data on INB-100 at 2025 TCTFebruary 14, 2025 | markets.businessinsider.comIN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AMLFebruary 14, 2025 | globenewswire.comJones Trading Upgrades IN8bio (INAB)February 12, 2025 | msn.comThis MIcro Cap Found Mid-Week Success On New Clinical DataFebruary 11, 2025 | msn.comIN8bio reports updated results from Phase 1 trial of INB-100February 11, 2025 | markets.businessinsider.comJones Trading lifts IN8bio stock rating to Buy, sets $1.20 targetFebruary 11, 2025 | msn.comMizuho Securities Keeps Their Buy Rating on IN8bio (INAB)February 11, 2025 | markets.businessinsider.comIN8bio, Inc: IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia PatientsFebruary 11, 2025 | finanznachrichten.deINB-100 shows promise in AML patient remission ratesFebruary 11, 2025 | msn.comIN8bio upgraded to Buy from Hold at JonesResearchFebruary 11, 2025 | markets.businessinsider.comJonesResearch upgrades IN8bio to Buy on ‘impressive’ AML dataFebruary 11, 2025 | markets.businessinsider.comIN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia PatientsFebruary 11, 2025 | globenewswire.comIN8bio gains extension to meet Nasdaq listing requirementsFebruary 8, 2025 | msn.comIN8bio to Present at Biotech Showcase 2025 in San FranciscoJanuary 6, 2025 | finance.yahoo.comIN8bio announces updated data for Phase 1 trial of INB-100December 11, 2024 | markets.businessinsider.comIN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual MeetingDecember 10, 2024 | globenewswire.comMizuho Securities Remains a Buy on IN8bio (INAB)November 27, 2024 | markets.businessinsider.comJonesTrading Sticks to Its Hold Rating for IN8bio (INAB)November 27, 2024 | markets.businessinsider.comINAB: Upcoming Presentations at SNO & ASHNovember 14, 2024 | msn.comIN8bio price target lowered to $8 from $12.50 at H.C. WainwrightNovember 14, 2024 | markets.businessinsider.comIN8bio Advances Cancer Therapies Amid Financial RestructuringNovember 14, 2024 | tipranks.comIN8bio, Inc: IN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 13, 2024 | finanznachrichten.deIN8bio Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 12, 2024 | globenewswire.comIN8bio Announces Plenary Oral Presentation at the 2024 Society for Neuro-Oncology (SNO) Annual MeetingNovember 12, 2024 | finance.yahoo.comIN8bio files to sell 55.49M shares of common stock for holdersNovember 5, 2024 | markets.businessinsider.comIN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual MeetingNovember 5, 2024 | finance.yahoo.comWall Street Set to Open Lower as Investors Await Earnings Report, Harker SpeechOctober 22, 2024 | msn.comIN8bio (NASDAQ:INAB) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comINAB: Restructuring Narrows Focus to AMLOctober 3, 2024 | finance.yahoo.comIN8bio Announces Pricing of $12.4 Million Private PlacementOctober 1, 2024 | markets.businessinsider.comIN8bio To Cut About 49% Of Jobs, Suspend Glioblastoma Development ProgramSeptember 5, 2024 | markets.businessinsider.comIN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid LeukemiaSeptember 4, 2024 | globenewswire.comIN8bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 29, 2024 | globenewswire.comIN8bio, Inc. (6JH.MU)August 23, 2024 | sg.finance.yahoo.comIN8bio Inc (6JH.BE)August 23, 2024 | sg.finance.yahoo.comINAB: AML & GBM Clinical UpdateAugust 14, 2024 | finance.yahoo.comJones Trading Downgrades IN8bio (INAB)August 14, 2024 | msn.comIN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of INB-100August 12, 2024 | globenewswire.comINAB Stock Earnings: IN8bio Misses EPS for Q2 2024August 9, 2024 | markets.businessinsider.comIN8bio Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 8, 2024 | finance.yahoo.com Remove Ads Get IN8bio News Delivered to You Automatically Sign up to receive the latest news and ratings for INAB and its competitors with MarketBeat's FREE daily newsletter. Email Address INAB Media Mentions By Week INAB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INAB News Sentiment▼0.470.77▲Average Medical News Sentiment INAB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INAB Articles This Week▼31▲INAB Articles Average Week Remove Ads Get IN8bio News Delivered to You Automatically Sign up to receive the latest news and ratings for INAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GNTA News Today THTX News Today PEPG News Today PYRGF News Today INZY News Today IKNA News Today CLLS News Today CLSD News Today IMAB News Today CUE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INAB) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMarch 18th: Gold SHOCK? On March 18th, an event is taking place that could completely shock the market. Stocks could go ballistic…...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump Shock to change everything Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...Centurion Publishing | SponsoredThis AI pick beats my 2016 Nvidia predictionThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
